Catalyst Wire Dossier Catalyst Wire Dossier

0.45% sodium chloride with 5% dextose (D5W) intravenous fluids

sodium chloride 0.45% with dextrose 5%
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 0.45% sodium chloride with 5% dextose (D5W) intravenous fluids, covering 2013-08-26 to 2013-08-26. Get the full timeline:

Most recent: Clinical Trial Update: 0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Hospitalized Children [Phase 3]

See pricing